The Prevalence of Food Sensitization Appears Not to Have Changed between 2 Melbourne Cohorts of High-Risk Infants Recruited 15 Years Apart
Rachel L Peters, Jennifer J Koplin, Katrina J Allen, Adrian J Lowe, Caroline J Lodge, Mimi LK Tang, Melissa Wake, Anne-Louise Ponsonby, Bircan Erbas, Michael J Abramson, David Hill, Lyle C Gurrin, Shyamali C Dharmage
The Journal of Allergy and Clinical Immunology: In Practice | ELSEVIER SCIENCE BV | Published : 2018
Related Projects (1)
The HealthNuts study was supported by funding from the National Health & Medical Research Council (NHMRC) of Australia, Ilhan Food Allergy Foundation, AnaphylaxiStop, the Charles and Sylvia Viertel Medical Research Foundation, the Victorian Government's Operational Infrastructure Support Program, and the NHMRC Centre for Food and Allergy Research. K. J. Allen, L. C. Gurrin, A. J. Lowe, J. J. Koplin, and S. C. Dharmage hold NHMRC awards. M. Wake was supported by an NHMRC award and Cure Kids New Zealand. The first 6 years of the Melbourne Atopy Cohort Study (MACS) was funded (study formula and staff) by Nestec Ltd, a subsidiary of Nestle Australia. The 12-year follow-up was supported by Victorian Asthma Foundation and 18-year and 25-year follow-ups have been funded by NHMRC. All bodies that have funded aspects of the MACS have had no role in interpretation or publication of study findings.